Implanting the enVista IOL

Show Description +

The enVista (Bausch + Lomb, Rochester, New York) is the first hydrophobic acrylic IOL to receive the FDA labeling claim of being 100% glistening-free. This lens combines the company's aspheric, aberration-free Advanced Optics technology with a new glistening-free material. It is intended to minimize posterior capsular opacification.

Posted: 10/31/2011

Implanting the enVista IOL

The enVista (Bausch + Lomb, Rochester, New York) is the first hydrophobic acrylic IOL to receive the FDA labeling claim of being 100% glistening-free. This lens combines the company's aspheric, aberration-free Advanced Optics technology with a new glistening-free material. It is intended to minimize posterior capsular opacification.

Posted: 10/31/2011

Please log in to leave a comment.

More in Cataract

Brazil Osher Lecture

Iqbal Ike K. Ahmed, MD, FRCSC

AAO Kelman Lecture

Professor Graham Barrett

ESCRS Heritage Lecture

Robert H. Osher, MD

ASCRS Binkhorst Lecture

Ronald Yeoh, FRCS, FRCOphth, DO, FAMS